暂无数据
暂无内容
在监管战略和商业化前景中维持对Axsome疗法的评级
Axsome Therapeutics, Inc.”s(纳斯达克股票代码:AXSM)利润展望
Axsome Therapeutics, Inc.(纳斯达克股票代码:AXSM)的业务可能即将取得重大成就,因此我们想对该公司有所了解。Axsome Therapeutics, Inc.,一家生物制药公司
Axsome Therapeutics, Inc.(纳斯达克股票代码:AXSM)第一季度业绩:以下是分析师对今年的预测
瑞穗将Axsome Therapeutics维持在买入状态
瑞穗将Axsome Therapeutics维持在买入状态
瑞穗将Axsome Therapeutics的目标股价从109.00美元下调至每股106.00美元
瑞穗将Axsome Therapeutics的目标股价从109.00美元下调至每股106.00美元
快讯 | 瑞穗维持对Axsome Therapeutics的买入,将目标股价下调至106美元
Salmon Klein : are you in $Macrogenics (MGNX.US)$ ? tell me when good to jump in
MangoXXXX Salmon Klein: Now
SlowndEasyTrades Salmon Klein: Do your own research , I think hovering in bottom and buy signal from pattern about to begin , do not follow me blindly my
Salmon Klein SlowndEasyTrades: I am waiting to reach 14.8 or so, but I am busy working, if it reached the bottom and you are in...any good feedback is always very welcomed bro...just that so thanks
SlowndEasyTrades Salmon Klein: Double higher bottom in intra-day might not hit below 14ish or if so still chance for 2 more trading sideways days, I am almost 25% down ( reason holding beyond top) anyway